Drug Database
SC

SC-001 (SP009 / SC001)

✓ Approved

Declion Pharmaceuticals · · Polypeptide

What is SC-001?

SC-001 is a polypeptide developed by Declion Pharmaceuticals. It is approved for therapeutic indications via injectable (others) or intradermal injection.

Drug Profile

Brand NamesSP009, SC001
CompanyDeclion Pharmaceuticals
Drug ClassPolypeptide
RouteInjectable (Others), Intradermal Injection
StatusApproved

Mechanism of Action

Molecular Targets

SC-001 acts on 1 molecular target:

()
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

SC-001 is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Surgical and medical proceduresBotulinum toxin injection✓ Approved

Related Research Articles

PubMedNature genetics2026-11-11

Efficient count-based models improve power and robustness for large-scale single-cell eQTL mapping.

Zhang Zixuan Eleanor ZE, Kim Artem A, Suboc Noah N, Mancuso Nicholas N et al.

Population-scale single-cell RNA sequencing enables mapping genetic effects on gene regulation at the cellular level (for example, single-cell expression quantitative trait loci (sc-eQTLs)). However, existing sc-eQTL mapping approaches are either not designed for analyzing sparse counts in single-cell RNA sequencing data or become computationally intractable at scale. Here we developed jaxQTL-an efficient pseudobulk sc-eQTL mapping framework using highly efficient count-based models. In simulations, we demonstrated that jaxQTL with a negative binomial model provides calibrated inference while outperforming linear models. In OneK1K data, jaxQTL identified 16% more eGenes than linear models, while running substantially faster than single-cell Poisson mixed effect models. We found that fine-mapped sc-eQTLs are more distal from transcription starting site than those identified in all cells (bulk-eQTLs; P = 1 × 10-4) and more enriched in cell-type-specific enhancers (P = 3 × 10-10), revealing distal regulatory effects that are missed in bulk tissues. Although sc-eQTLs are largely shared across cell types, cell-type-specificity increases with distance to transcription starting site. Finally, sc-eQTLs explain a greater proportion of single nucleotide polymorphism-heritability than bulk-eQTLs across 16 blood and immune-related traits (9.90 ± 0.88% versus 6.10 ± 0.76%) and prioritize disease-associated genes missed by the bulk approach (such as IL6ST), improving, but not closing, the missing link between genome-wide association studies and eQTLs.

PubMedNano letters2026-11-11

Atomic Lift-Off of Wafer-Scale Single-Crystalline Gold Membranes Enables Buried-Interface Epitaxy for Flexible Oxide Electronics.

Sun Yongbin Y, Chi Hanwen H, Shen Ziyue Z, Wang Kaixin K et al.

Flexible oxide electronics require inorganic semiconductors that maintain high-performance under bending, yet scalable approaches to wafer-scale single-crystalline (SC) oxide films and, critically, atomically sharp metal/oxide contacts remain limited. Here, we introduce a buried-interface epitaxy strategy based on atomic lift-off of epitaxial metal films to create atomically defined SC metal/oxide heterostructures in flexible architectures. We fabricate 2-in. freestanding SC Au(111) membranes and employ film-flipping to expose the originally buried Au/Si epitaxial interface as an intrinsically atomically flat growth surface. This converts conventional surface deposition into interface deposition, enabling wafer-scale epitaxial Cu2O(111)/Au with a flat interface. The interface-deposited flexible Cu2O exhibits nearly 2-fold higher carrier mobility and photocurrent, while maintaining stable transport under bending. Flexible Cu2O photocathodes further exhibit 1.6 times higher full-angle light harvesting and 5.6 times higher photocurrent-to-mass metrics compared with rigid counterparts. This work establishes freestanding SC metals as transferable epitaxial templates for flexible oxide electronics and energy devices.

PubMedBMC public health2026-11-11

Demographic and psychosocial factors associated with adjustment and reintegration to civilian life: a prospective and cross-sectional analysis of transitioning and ex-serving military personnel.

Romaniuk Madeline M, Fisher Gina G, Batterham Philip J PJ

The prevalence of reintegration and adjustment difficulties among military veterans transitioning to civilian life is high, with maladjustment linked to poor mental health and increased suicide risk. Identifying factors predictive of adjustment may inform the development of preventative screening and intervention strategies. This study aimed to determine significant demographic and psychosocial factors associated with adjustment and reintegration using both cross-sectional and prospective methods. A convenience sample of 866 transitioning and ex-serving military personnel completed demographic, service, and psychosocial questionnaires online. A subset provided responses before and after permanent separation from service. Binary logistic regression analyses were used to assess the association between key variables and self-reported adjustment and reintegration to civilian life. The effects of the predictor variables on the outcome variable were estimated by adjusted odds ratios with 95% confidence intervals. For ex-serving participants, significant associations were found between adjustment/reintegration and gender (p = .045), education level (p = .031), marital status (p = .022), rank at discharge (p < .001), employment status (p < .001), number of years since discharge (p = .001), PTSD symptoms (p < .001), purpose and connection (p < .001), help seeking (p = .019), and beliefs about civilians (p < .001). For current serving participants, significant associations included employment status (p < .001) anger and perceived failure (p = .02) and feeling unprepared for civilian life (p = .002). Veterans at higher risk of maladjustment include those who are unemployed or on a medical pension, are single, male, from lower ranks with lower education, and with higher symptoms of PTSD, higher levels of anger, feelings of failure, and feeling unprepared for the transition to civilian life prior to separation. Embedding population-level monitoring of this high-risk demographic group, along with individual-level screening and targeting of these factors may assist in improving adjustment and reintegration outcomes in this population.

PubMedAnalytical chemistry2026-11-11

When Two Interfaces Meet: A Unified Theory for Thin-Membrane Voltammetric Ion Selective Electrodes.

López-Asanza Javier J, Zamudio Edward E, Molina Angela A, Crespo Gastón A GA et al.

Voltammetric solid-contact ion-selective electrodes (SC-ISEs) exhibit electrochemical responses that arise from the coupling of heterogeneous electron transfer at the electrode-membrane interface with ion transfer at the membrane-sample boundary. In this work, a novel theoretical framework is developed for voltammetric SC-ISEs based on thin membranes, capturing the intrinsic consequences of coupling two polarized interfaces in series under markedly different mass-transport conditions in the membrane and solution phases. The theory describes the current/charge-potential-time responses and the corresponding interfacial potentials and dynamic ion and redox-species concentrations, accounting for the effects of membrane and solution composition, membrane thickness, and experimental timescale. Besides, the theory enables quantitative analysis of experimental voltammetric outcomes. A systematic classification of cyclic voltammetry (CV) responses is obtained in terms of three dimensionless parameters that quantify ion availability in the sample solution relative to the confined membrane. Simple relationships for peak positions and practical diagnostic criteria based on CV shape and scan-rate dependence are derived to verify thin-membrane conditions and the absence of kinetic or ohmic limitations, identifying indeed whether charge compensation proceeds via ion release or uptake.

PubMedMedicine2026-11-11

Efficacy and influencing factors of rituximab in idiopathic membranous nephropathy: A real-world retrospective study.

Xu Xiaofei X, Zhou Qiwei Q, Li Subo S, Zhang Xiaoru X et al.

This study aims to investigate the efficacy and influencing factors of rituximab (RTX) in the treatment of idiopathic membranous nephropathy (IMN). A total of 46 patients with IMN visited and followed up regularly in our hospital were included in this study. The patients were divided into 2 groups, with 23 patients receiving RTX treatment (RTX group) and 23 patients receiving treatment with cyclophosphamide (CTX group). The clinical data of the patients, including urine examination, blood test, efficacy evaluation results, and adverse events (AEs) were analyzed retrospectively. The changes in clinical and biochemical indicators were compared in RTX groups before and after treatment, and the clinical efficacy and influencing factors of RTX treatment for IMN were evaluated. After 6 months of treatment, in the RTX group, compared to baseline, there was a significant decrease in 24-hour urine protein, total cholesterol, and B lymphocyte count (P < .001, P = .010, P < .001), while albumin (ALB), globulin, and natural killer cells showed a significant increase compared to baseline (P < .001, P < .001, P < .001). After 6 months of treatment, the RTX group showed significantly higher glomerular filtration rate, higher levels of ALB, and higher levels of globulin compared to the CTX group, with statistical significance (P = .042, P = .003, P < .001). Among patients with positive anti-PLA2R antibodies at baseline, the antibody clearance rate at 6 months was significantly higher in the RTX group than in the CTX group (P = .035). By the end of follow-up, the overall remission rates were 91.3% for the RTX group and 87.0% for the CTX group, with no statistically significant difference between the 2 groups (P > .99). A univariate analysis of the correlation between clinical characteristics, laboratory tests, and the efficacy of RTX treatment found that lower baseline 24-hour urine protein levels appeared to be associated with a higher likelihood of achieving remission (P = .035). AEs were observed in 17.4% of RTX-treated patients versus 52.2% of CTX-treated patients (P = .030). RTX appeared to be effective in patients with IMN and was associated with a more favorable safety profile compared with CTX.

PubMedMedicine2026-11-11

Application effect of an evidence-based early functional exercise program in kidney transplant recipients.

Zhang Miao M, Shi Peili P, Su Xiaowei X, Wang Ying Y et al.

This study evaluates the clinical application effect of an evidence-based early functional exercise program in kidney transplant recipients. A retrospective study design was adopted. A total of 84 patients who underwent kidney transplantation in a tertiary hospital from January 2025 to March 2026 were selected as the study subjects. According to whether they received the evidence-based early functional exercise program, they were divided into a control group (conventional care) and an evidence-based practice (EBP) group (evidence-based program care), with 42 cases in each group. Propensity score matching was used to ensure baseline comparability between the 2 groups. Early functional recovery indicators, activities of daily living, pain scores, self-efficacy, and postoperative complication rates were compared between the 2 groups. The time to 1st postoperative ambulation in the EBP group was significantly earlier than that in the control group (median 23.0 vs 98.0 hours, P < .001), and the rate of ambulation within 24 hours was significantly higher (66.7% vs 7.1%, P < .001). The time to 1st flatus, time to 1st defecation, and postoperative hospital stay in this group were significantly better than those in the control group (P < .001). At discharge, the Barthel index score (88.2 ± 5.9 vs 75.8 ± 7.6, P < .001) and the proportion of patients with complete independence in daily living (47.6% vs 14.3%, P = .005) in the EBP group were significantly higher than those in the control group. At 3 days postoperatively, the numeric rating scale score in the EBP group was lower than that in the control group (median 3.5 vs 5.0, P < .001); the improvement in self-efficacy score was also significantly better than that in the control group (P < .001). In this retrospective propensity score-matched cohort, receipt of the evidence-based early functional exercise program was associated with earlier postoperative ambulation and gastrointestinal recovery, better activities of daily living and self-efficacy, lower pain scores, and a lower observed complication rate, without an observed increase in falls. These findings suggest that the program may have potential clinical value, although prospective multicenter studies are needed to confirm causality and generalizability.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about SC-001